Loading...
A proposal for dose-adjustment of dabigatran etexilate in atrial fibrillation guided by thrombin time
Dabigatran is an oral anticoagulant that is increasingly used for atrial fibrillation (AF). Presently, many authorities state that routine laboratory coagulation monitoring is not required. However, data have recently been published demonstrating that higher trough plasma dabigatran concentrations a...
Saved in:
| Published in: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BlackWell Publishing Ltd
2014
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4243910/ https://ncbi.nlm.nih.gov/pubmed/24592851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12364 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|